Publikationen in Zusammenarbeit mit Forschern von University of Rome Tor Vergata (8)

2024

  1. Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023)

    Journal of Osteopathic Medicine

2016

  1. Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 4, pp. 1056-1062

2011

  1. European guidelines on the clinical management of HIV-1 tropism testing

    The Lancet Infectious Diseases, Vol. 11, Núm. 5, pp. 394-407

  2. European recommendations for the clinical use of HIV drug resistance testing: 2011 update

    AIDS Reviews, Vol. 13, Núm. 2, pp. 77-108

2009

  1. When and how to use maraviroc in HIV-infected patients

    AIDS, Vol. 23, Núm. 18, pp. 2377-2385

2008

  1. Optimal use of maraviroc in clinical practice

    AIDS, Vol. 22, Núm. 17, pp. 2231-2240

2004

  1. Updated European recommendations for the clinical use of HIV drug resistance testing

    Antiviral Therapy, Vol. 9, Núm. 6, pp. 829-848

2003

  1. Lamivudine resistance in human T-cell leukemia virus type 1 may be due to a polymorphism at codon 118 (V→i) of the reverse transcriptase (multiple letters)

    Antimicrobial Agents and Chemotherapy